Three dimensional cellular microarray platform for human neural stem cell differentiation and toxicology

Stem Cell Research

Volumn 13, Issue 1, 2014, Pages 36-47

  Meli, Luciana ^a   Barbosa, Hélder S C ^b   Hickey, Anne Marie ^a   Gasimli, Leyla ^c   Nierode, Gregory ^a   Diogo, Maria Margarida ^b   Linhardt, Robert J ^a,c,d   Cabral, Joaquim M S ^b   Dordick, Jonathan S ^a,c  

^a RENSSELAER POLYTECHNIC INSTITUTE   (United States)

^b INSTITUTO SUPERIOR TÉCNICO   (Portugal)

^c RENSSELAER POLYTECHNIC INSTITUTE   (United States)

^d Rensselaer Polytechnic Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; FLUOROURACIL; PARACETAMOL; PHALLOIDIN; RETINOIC ACID;

ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CARCINOMA CELL LINE; CELL DIFFERENTIATION; CELL DIVISION; CELL GROWTH; CELL PROLIFERATION; CELL VIABILITY; CELL VIABILITY ASSAY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG CYTOTOXICITY; EMBRYO; EMBRYONIC STEM CELL; FETUS; GROWTH RATE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IC 50; IMMUNOFLUORESCENCE; IMMUNOFLUORESCENCE TEST; IN VITRO STUDY; MICROARRAY ANALYSIS; NEURAL STEM CELL; NEURITE; OLIGODENDROGLIA; PHENOTYPE; PRIORITY JOURNAL; PROGENY; SURVIVAL FACTOR; THREE DIMENSIONAL CELLULAR MICROARRAY; WESTERN BLOTTING; CULTURE TECHNIQUE; CYTOLOGY; DEVICES; GLIA; PHYSIOLOGY; PROCEDURES;

CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL PROLIFERATION; HUMANS; MICROARRAY ANALYSIS; NEURAL STEM CELLS; NEUROGLIA;

EID: 84899847797     PISSN: 18735061     EISSN: 18767753     Source Type: Journal    
DOI: 10.1016/j.scr.2014.04.004     Document Type: Article

References (33)

1. Adams J., Lammer E.J. Relationship between dysmorphology and neuropsychological function in children exposed to isotretinoin "in utero.". Functional Neuroteratology of Short-term Exposure to Drugs 1991, 59-70. Teikyo University Press, Tokyo. T. Fujii, C.J. Boer (Eds.).
2. Andersen M.E., Krewski D. Toxicity testing in the 21st century: bringing the vision to life. Toxicol. Sci. 2009, 107(2):324-330.
3. Ashton R.S., et al. Scaffolds based on degradable alginate hydrogels and poly(lactide-co-glycolide) microspheres for stem cell culture. Biomaterials 2007, 28(36):5518-5525.
4. Bal-Price A.K., et al. Relevance of in vitro neurotoxicity testing for regulatory requirements: challenges to be considered. Neurotoxicol. Teratol. 2010, 32(1):36-41.
5. Baud O. Postnatal steroid treatment and brain development. Arch. Dis. Child Fetal Neonatal Ed. 2004, 89:F96-F100.
6. Bogdahn U., et al. Therapy of malignant brain tumors: comparison of the in vitro activities of vidarabin-monophosphate, BCNU and 5-fluorouracil. Acta Neurol. Scand. 1987, 75:28-36.
7. Breier J.M., et al. Development of a high-throughput screening assay for chemical effects on proliferation and viability of immortalized human neural progenitor cells. Toxicol. Sci. 2008, 105(1):119-133.
8. Breier J.M., et al. Neural progenitor cells as models for high-throughput screens of developmental neurotoxicity: state of the science. Neurotoxicol. Teratol. 2010, 32(1):4-15.
9. Buzanska L., et al. A human stem cell-based model for identifying adverse effects of organic and inorganic chemicals on the developing nervous system. Stem Cells (Dayton, Ohio) 2009, 27(10):2591-2601.
10. Chauffert B., Dimanche-Boitrel M. New insights into the kinetic resistance to anticancer agents. Cytotoxicology 1998, 27:225-235.
11. Chayosumrit M., Tuch B., Sidhu K. Alginate microcapsule for propagation and directed differentiation of hESCs to definitive endoderm. Biogeosciences 2010, 31:505-514.
12. Cheng K., Lai Y., Kisaalita W.S. Three-dimensional polymer scaffolds for high throughput cell-based assay systems. Biomaterials 2008, 29:2802-2812.
13. Clemedson C., Kolman A., Forsby A. The integrated acute systemic toxicity project (ACuteTox) for the optimisation and validation of alternative in vitro tests. Altern. Lab. Anim. 2007, 35:33-38.
14. Costa L.G., Fattori V., Giordano G. An in vitro approach to assess the toxicity of certain food contaminants: methylmercury and poly-chlorinated biphenyls. Toxicology 2007, 237:65-76.
15. National Research Council Toxicity Testing in the 21st Century: A Vision and a Strategy 2007, National Academies Press, Washington, DC.
16. Dietrich J., et al. CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo. J. Biol. 2006, 5(22):1-23.
17. Donato R., et al. Differential development of neuronal physiological responsiveness in two human neural stem cell lines. BMC Neurosci. 2007, 8:36.
18. Fernandes T.G., et al. On-chip cell-based microarray immunofluorescence assay for high-throughput analysis of target proteins. Anal. Chem. 2008, 80(17):6633-6639.
19. Fernandes T.G., et al. High-throughput cellular microarray platforms: applications in drug discovery, toxicology and stem cell research. Trends Biotechnol. 2009, 27(6):342-349.
20. Krencik R., et al. Specification of transplantable astroglial subtypes from human pluripotent stem cells. Nat. Biotechnol. 2011, 29(6):528-534.
21. Laustriat D., Gide J., Peschanski M. Human pluripotent stem cells in drug discovery and predictive toxicology. Biochem. Soc. Trans. 2010, 38(4):1051-1057.
22. Lee M.-Y., et al. Three-dimensional cellular microarray for high-throughput toxicology assays. Proc. Natl. Acad. Sci. U. S. A. 2008, 105(1):59-63.
23. Longley D.B., Harkin D.P., Johnston P.G. 5-Fluorouracil: mechanisms of action and clinical strategies. Nat. Rev. Cancer 2003, 3(5):330-338.
24. Martin-Ibanez R., et al. Interplay of leukemia inhibitory factor and retinoic acid on neural differentiation of mouse embryonic stem cells. J. Neurosci. Res. 2007, 85:286-2701.
25. Meli L., et al. Influence of a three-dimensional, microarray environment on human cell culture in drug screening systems. Biomaterials 2012, 33(35):9087-9096.
26. Miljan E.A. ReNcell Human Neural Progenitors: Renewable and Consistent Supply of Human Functional Neurons 2007, Millipore Technical Publications.
27. Nutt C.L., et al. Differential expression of drug resistance genes and chemosensitivity in glial cell lineages correlate with differential response of oligodendrogliomas and astrocytomas to chemotherapy. Cancer Res. 2000, 60:4812-4818.
28. Paquette J.A., et al. Assessment of the embryonic stem cell test and application and use in the pharmaceutical industry. Birth Defects Res B 2008, 83:104-111.
29. Rajasingh J., Bright J.J. 15-Deoxy-delta12,14-prostaglanding J2 regulates leukemia inhibitory factor signaling through JAK-STAT pathway in mouse embryonic stem cells. Exp. Cell Res. 2006, 312:2538-2546.
30. Rieske P., et al. A population of human brain parenchymal cells express markers of glial, neuronal and early neural cells and differentiate into cells of neuronal and glial lineages. Eur. J. Neurosci. 2007, 25(1):31-37.
31. Saunders J.B., Wright N., Lewis K.O. Predicting outcome of paracetamol poisoning by using 14C-aminopyrine breath test. Br. Med. J. 1980, 280:279-280.
32. Trosko J.E., Chang C. Factors to consider in the use of stem cells for pharmaceutic drug development and for chemical safety assessment. Toxicology 2010, 270:18-34.
33. Wang L., Kisaalita W.S. Characterization of micropatterned nanofibrous scaffolds for neural network. J. Biomed. Mater. Res. B Appl. Biomater. 2010, 94B:238-249.